CYTOSTATIC DRUGS IN THE TREATMENT OF SECONDARY DISEASE FOLLOWING HOMOLOGOUS BONE MARROW TRANSPLANTATION: EXTRAPOLATION FROM THE MOUSE TO THE PRIMATE*
- 16 December 1966
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 129 (1), 340-354
- https://doi.org/10.1111/j.1749-6632.1966.tb12863.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- LEUKOAGGLUTINATING ISOANTIBODIES IN RHESUS MONKEYSTransplantation, 1965
- Successful Allogenic Bone Marrow Transplantation in Man: Chimerism, Induced Specific Tolerance and Possible Anti-Leukemic EffectsBlood, 1965
- MARROW TRANSPLANTS IN LETHALLY IRRADIATED DOGS: THE EFFECT OF METHOTREXATE ON SURVIVAL OF THE HOST AND THE HOMOGRAFT*Transplantation, 1963
- A Method of Reducing the Incidence of the Secondary Syndrome in Allogenic Marrow TransplantationBlood, 1963
- Homologous Bone Marrow Transplantation in Dogs Receiving X-Radiation plus Urethan or 6-MercaptopurineBlood, 1963
- Marrow Transplants in Lethally Irradiated Dogs Given MethotrexateBlood, 1962
- Modification of Runt Disease in Mice by Various MeansPublished by Wiley ,1962
- Treatment of Secondary Disease in Radiation ChimaerasInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1961
- Homografts of Bone Marrow in Dogs After Lethal Total-Body RadiationBlood, 1959
- Alteration of Homograft Reaction by A-methopterin in Lethally Irradiated Mice Treated with Homologous MarrowExperimental Biology and Medicine, 1958